- Marinomed will apply the Marinosolv solubilization technology to improve target compounds with the goal of developing products with differentiated pharmacological profiles
- The project covers the proof-of-concept evaluation and future development of selected products with exclusivity rights for Aché in Latin America
- Second long-term partnership for Marinomed’s Solv4U business area to generate royalites after successful market entry
The full press release is available as download here: